Posted by Teresa Graham on Jan 25th, 2026
Globus Medical, Inc. (NYSE:GMED – Get Free Report) has received an average recommendation of “Moderate Buy” from the fifteen research firms that are covering the stock, MarketBeat reports. Seven research analysts...
More of this article »